Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | PYGB | P11216 | 7/20 | 0.37 |
| ▸ | PYGL | P06737 | 3/20 | 0.37 |
| ▸ | PYGM | P11217 | 2/20 | 0.37 |
| ▸ | CDK1 | P06493 | 1/20 | 0.36 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.36 |
| ▸ | GBA1 | P04062 | 2/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19242663 | 1.00 | MEN1 (0.51) | MEN1KMT2APYGBPYGLPYGM | |
| SCHEMBL6376667 | 1.00 | MEN1 (0.51) | MEN1KMT2APYGBPYGLPYGM | |
| SCHEMBL2853265 | 1.00 | MEN1 (0.51) | MEN1KMT2APYGBPYGLPYGM | |
| SCHEMBL8522586 | 1.00 | MEN1 (0.51) | MEN1KMT2APYGBPYGLPYGM | |
| SCHEMBL4969252 | 1.00 | MEN1 (0.51) | MEN1KMT2APYGBPYGLPYGM | |
| SCHEMBL2857459 | 1.00 | MEN1 (0.51) | MEN1KMT2APYGBPYGLPYGM | |
| SCHEMBL15814770 | 1.00 | MEN1 (0.51) | MEN1KMT2APYGBPYGLPYGM | |
| SCHEMBL9006 | 1.00 | MEN1 (0.51) | MEN1KMT2APYGBPYGLPYGM | |
| SCHEMBL10013929 | 1.00 | MEN1 (0.51) | MEN1KMT2APYGBPYGLPYGM | |
| SCHEMBL15959591 | 1.00 | MEN1 (0.51) | MEN1KMT2APYGBPYGLPYGM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11692058-B2 | Synthesis of functional polyurethanes and polyesters from biomass-derived monomers | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2023-07-04 | — | — | US | disclosed |
| US-9732101-B2 | Bioreversible boronates for delivery of molecules into cells | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2017-08-15 | — | — | US | disclosed |
| EP-3088497-A1 | BRIQUETTES AND METHOD FOR PRODUCING SAME | Posco (KR) | 2016-11-02 | — | — | EP | disclosed |
| US-20160083706-A1 | BORONATE-MEDIATED DELIVERY OF MOLECULES INTO CELLS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-03-24 | — | — | US | disclosed |
| US-20160024122-A1 | BIOREVERSIBLE BORONATES FOR DELIVERY OF MOLECULES INTO CELLS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-01-28 | — | — | US | disclosed |
| US-9234048-B2 | Boronate-mediated delivery of molecules into cells | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2016-01-12 | — | — | US | disclosed |
| US-9144785-B2 | Catalyst for hydrolyzing cellulose or hemicellulose and method for producing sugar-containing solution employing same | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2015-09-29 | — | — | US | disclosed |
| US-20130196433-A1 | Boronate-Mediated Delivery of Molecules into Cells | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2013-08-01 | — | — | US | disclosed |
| US-20120240921-A1 | CATALYST FOR HYDROLYZING CELLULOSE OR HEMICELLULOSE AND METHOD FOR PRODUCING SUGAR-CONTAINING SOLUTION EMPLOYING SAME | SHOWA DENKO K.K. (JP) | 2012-09-27 | — | — | US | disclosed |
| US-7172682-B2 | Enzyme immobilization for electroosmotic flow | RENSSELAER POLYTECHNIC INSTITUTE (US) | 2007-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160024122-A1 | BIOREVERSIBLE BORONATES FOR DELIVERY OF MOLECULES INTO CELLS | BAG6, BCAP31, PHB1 | MEN1 806/4885KMT2A 3068/4885PYGB 903/4885 |
| US-20130196433-A1 | Boronate-Mediated Delivery of Molecules into Cells | BCAP31, PHAX, BTD | MEN1 1395/4885KMT2A 3901/4885PYGB 432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.